(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide

C174H225F6N33O7 — CID 167582397

IUPAC(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide
SMILESCC(C)C[C@@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CC(C)C[C@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CN(C)[C@H](CNC(=O)C[C@@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.Cc1ccc([C@@H](CC(=O)NC[C@H](Cc2ccc3[nH]ncc3c2)N(C)C)C2(C(C)(F)F)CC2)cn1
InChIInChI=1S/C26H33F2N5O.2C25H31F2N5O.2C25H34N4O.2C24H31N5O/c1-17-5-7-19(14-29-17)22(26(9-10-26)25(2,27)28)13-24(34)30-16-21(33(3)4)12-18-6-8-23-20(11-18)15-31-32-23;2*1-24(26,27)25(8-9-25)21(18-5-4-10-28-14-18)13-23(33)29-16-20(32(2)3)12-17-6-7-22-19(11-17)15-30-31-22;2*1-18(2)12-21(20-8-6-5-7-9-20)15-25(30)26-17-23(29(3)4)14-19-10-11-24-22(13-19)16-27-28-24;2*1-29(2)22(12-18-7-8-23-21(11-18)15-27-28-23)16-26-24(30)13-20(10-17-5-6-17)19-4-3-9-25-14-19/h5-8,11,14-15,21-22H,9-10,12-13,16H2,1-4H3,(H,30,34)(H,31,32);2*4-7,10-11,14-15,20-21H,8-9,12-13,16H2,1-3H3,(H,29,33)(H,30,31);2*5-11,13,16,18,21,23H,12,14-15,17H2,1-4H3,(H,26,30)(H,27,28);2*3-4,7-9,11,14-15,17,20,22H,5-6,10,12-13,16H2,1-2H3,(H,26,30)(H,27,28)/t21-,22+;20-,21+;20-,21-;21-,23+;21-,23-;20-,22+;20-,22-/m0001010/s1
InChIKeyHIRQOIPAOWDTLJ-ILBPDMTFSA-N
MW3004.93 g/mol
LogP28.56
Rot. Bonds70

About (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide

(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide (PubChem CID 167582397) has the molecular formula C174H225F6N33O7 and a molecular weight of 3004.93 g/mol. Its IUPAC name is (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide.

Molecular Properties

Compound Name(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide
PubChem CID167582397
Molecular FormulaC174H225F6N33O7
Molecular Weight3004.93 g/mol
Exact Mass3002.82
IUPAC Name(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide
SMILESCC(C)C[C@@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CC(C)C[C@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CN(C)[C@H](CNC(=O)C[C@@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.Cc1ccc([C@@H](CC(=O)NC[C@H](Cc2ccc3[nH]ncc3c2)N(C)C)C2(C(C)(F)F)CC2)cn1
InChIInChI=1S/C26H33F2N5O.2C25H31F2N5O.2C25H34N4O.2C24H31N5O/c1-17-5-7-19(14-29-17)22(26(9-10-26)25(2,27)28)13-24(34)30-16-21(33(3)4)12-18-6-8-23-20(11-18)15-31-32-23;2*1-24(26,27)25(8-9-25)21(18-5-4-10-28-14-18)13-23(33)29-16-20(32(2)3)12-17-6-7-22-19(11-17)15-30-31-22;2*1-18(2)12-21(20-8-6-5-7-9-20)15-25(30)26-17-23(29(3)4)14-19-10-11-24-22(13-19)16-27-28-24;2*1-29(2)22(12-18-7-8-23-21(11-18)15-27-28-23)16-26-24(30)13-20(10-17-5-6-17)19-4-3-9-25-14-19/h5-8,11,14-15,21-22H,9-10,12-13,16H2,1-4H3,(H,30,34)(H,31,32);2*4-7,10-11,14-15,20-21H,8-9,12-13,16H2,1-3H3,(H,29,33)(H,30,31);2*5-11,13,16,18,21,23H,12,14-15,17H2,1-4H3,(H,26,30)(H,27,28);2*3-4,7-9,11,14-15,17,20,22H,5-6,10,12-13,16H2,1-2H3,(H,26,30)(H,27,28)/t21-,22+;20-,21+;20-,21-;21-,23+;21-,23-;20-,22+;20-,22-/m0001010/s1
InChIKeyHIRQOIPAOWDTLJ-ILBPDMTFSA-N
XLogP28.56
TPSA491.59 Ų
H-Bond Donors14
H-Bond Acceptors26
Rotatable Bonds70
Heavy Atoms220
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5003004.93
LogP ≤ 528.56
H-Bond Donors ≤ 514
H-Bond Acceptors ≤ 1026

Analyze (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

5-(5-fluoro-3-pyridinyl)-1-[1-[[5-[(5-pyridin-3-yl-1H-indazole-3-carbonyl)amino]-2-pyridinyl]methyl]pyrrolidin-3-yl]-N-[6-(trifluoromethyl)-3-pyridinyl]indazole-3-carboxamide
CID 144555306
5-(5-amino-3-pyridinyl)-N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(azetidin-1-ylmethyl)-3-pyridinyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157093602
5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-[6-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;5-(5-piperidin-1-yl-3-pyridinyl)-N-[6-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157147381
5-[5-(dimethylcarbamoylamino)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide;5-(5-morpholin-4-yl-3-pyridinyl)-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide;5-(5-piperidin-1-yl-3-pyridinyl)-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide;5-[5-(pyrrolidin-1-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide
CID 157157559
5-(5-amino-3-pyridinyl)-N-[2-(cyclopropanecarbonylamino)phenyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide;N-[2-(cyclopropanecarbonylamino)phenyl]-5-(5-pyrrolidin-1-yl-3-pyridinyl)-1H-indazole-3-carboxamide
CID 157161323
5-(5-amino-3-pyridinyl)-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(4,4-difluoropiperidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;5-[5-[(3,3-difluoropyrrolidin-1-yl)methyl]-3-pyridinyl]-N-[6-[(dimethylamino)methyl]-3-pyridinyl]-1H-indazole-3-carboxamide;N-[6-[(dimethylamino)methyl]-3-pyridinyl]-5-pyridin-3-yl-1H-indazole-3-carboxamide
CID 157165576
(4R)-4-[3-[3-(1,1-difluoroethyl)phenyl]-2-pyridinyl]-5-(3,5-difluorophenyl)-1-(5-fluoro-1H-indol-3-yl)pentan-2-one;3-[2-[(1S)-2-(3,5-difluorophenyl)-1-[(2-indazol-1-ylacetyl)amino]ethyl]-3-pyridinyl]-N-methylbenzamide;2-(5-fluoro-1H-indol-3-yl)-N-[(1S)-2-(3-fluoro-5-methylphenyl)-1-[3-(2-methylphenyl)-2-pyridinyl]ethyl]acetamide;2-(5-fluoro-1H-indol-3-yl)-N-[(1S)-2-(3-fluoro-5-methylphenyl)-1-(3-quinolin-3-yl-2-pyridinyl)ethyl]acetamide
CID 157181828
(4R)-1-[3,5-bis(difluoromethyl)pyrazol-1-yl]-4-[3-(7H-cyclopenta[b]pyridin-3-yl)-2-pyridinyl]-5-(3,5-difluorophenyl)pentan-2-one;5-[2-[(1S)-1-[(2-cyclopentyl-2-phenylacetyl)amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-1-[2-[5-cyclopropyl-3-(trifluoromethyl)pyrazol-1-yl]butanoylamino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;N-[(1S)-2-(3,5-difluorophenyl)-1-[3-(4-methylphenyl)-2-pyridinyl]ethyl]-2-[5-(trifluoromethyl)-1H-indol-3-yl]acetamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[(2-pyrrolo[3,2-c]pyridin-1-ylacetyl)amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 157206651
(4R)-4-[3-[3-(1-aminoethenyl)-4-fluorophenyl]-2-pyridinyl]-5-(3,5-difluorophenyl)-1-[3-(trifluoromethyl)-1,4,6,7-tetrahydropyrazolo[4,3-c]pyridin-5-yl]pentan-2-one;(4R)-1-[3,5-bis(difluoromethyl)pyrazol-1-yl]-4-[3-(7H-cyclopenta[b]pyridin-3-yl)-2-pyridinyl]-5-(3,5-difluorophenyl)pentan-2-one;5-[2-[(2R)-5-cyclopentyl-1-(3,5-difluorophenyl)-4-oxo-5-phenylpentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;(4R)-5-(3,5-difluorophenyl)-4-[3-(4-methylphenyl)-2-pyridinyl]-1-[5-(trifluoromethyl)-1H-indol-3-yl]pentan-2-one;5-[2-[(2R)-1-(3,5-difluorophenyl)-4-oxo-5-pyrrolo[3,2-c]pyridin-1-ylpentan-2-yl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 157245939
2-[4-[(3S)-4,4-difluoro-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;2-[4-[(3R)-4,4-difluoro-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;2-[4-[(3R)-5,5-difluoro-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;2-[4-[(3S)-5,5-difluoro-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;2-[4-(4,4-difluoro-3-methylpiperidin-3-yl)phenyl]indazole-7-carboxamide;5-fluoro-2-[3-fluoro-4-[(3S)-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;5-fluoro-2-[3-fluoro-4-[(3R)-3-methylpiperidin-3-yl]phenyl]indazole-7-carboxamide;5-fluoro-2-[3-fluoro-4-(3-methylpiperidin-3-yl)phenyl]indazole-7-carboxamide
CID 157248748
bis(N-(6-methyl-3-pyridinyl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide);5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-pyridin-3-yl-1H-indazole-3-carboxamide;5-[5-(morpholin-4-ylmethyl)-3-pyridinyl]-N-[4-(trifluoromethyl)phenyl]-1H-indazole-3-carboxamide;N-(6-phenyl-3-pyridinyl)-5-[5-(piperidin-1-ylmethyl)-3-pyridinyl]-1H-indazole-3-carboxamide
CID 157275842
5-[2-[(1S)-1-[[(2S)-2-(3-acetylindol-1-yl)butanoyl]amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluorobenzamide;5-[2-[(1S)-1-[[(2R)-2-(3-acetylindol-1-yl)butanoyl]amino]-2-(3,5-difluorophenyl)ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2R)-2-[5,6-dimethyl-3-(trifluoromethyl)indazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluorobenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2S)-2-[5,6-dimethyl-3-(trifluoromethyl)indazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide;5-[2-[(1S)-2-(3,5-difluorophenyl)-1-[[(2S)-2-[4-(trifluoromethyl)pyrazol-1-yl]butanoyl]amino]ethyl]-3-pyridinyl]-2-fluoro-N-methylbenzamide
CID 157314839

Frequently Asked Questions

What is the IUPAC name of (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide?
The IUPAC name of (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide (CID 167582397) is (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide.
What is the SMILES notation for (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide?
The canonical SMILES for (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide is CC(C)C[C@@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CC(C)C[C@H](CC(=O)NC[C@H](Cc1ccc2[nH]ncc2c1)N(C)C)c1ccccc1.CN(C)[C@H](CNC(=O)C[C@@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](CC1CC1)c1cccnc1)Cc1ccc2[nH]ncc2c1.CN(C)[C@H](CNC(=O)C[C@H](c1cccnc1)C1(C(C)(F)F)CC1)Cc1ccc2[nH]ncc2c1.Cc1ccc([C@@H](CC(=O)NC[C@H](Cc2ccc3[nH]ncc3c2)N(C)C)C2(C(C)(F)F)CC2)cn1.
What is the InChIKey of (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide?
The InChIKey is HIRQOIPAOWDTLJ-ILBPDMTFSA-N. The full InChI is InChI=1S/C26H33F2N5O.2C25H31F2N5O.2C25H34N4O.2C24H31N5O/c1-17-5-7-19(14-29-17)22(26(9-10-26)25(2,27)28)13-24(34)30-16-21(33(3)4)12-18-6-8-23-20(11-18)15-31-32-23;2*1-24(26,27)25(8-9-25)21(18-5-4-10-28-14-18)13-23(33)29-16-20(32(2)3)12-17-6-7-22-19(11-17)15-30-31-22;2*1-18(2)12-21(20-8-6-5-7-9-20)15-25(30)26-17-23(29(3)4)14-19-10-11-24-22(13-19)16-27-28-24;2*1-29(2)22(12-18-7-8-23-21(11-18)15-27-28-23)16-26-24(30)13-20(10-17-5-6-17)19-4-3-9-25-14-19/h5-8,11,14-15,21-22H,9-10,12-13,16H2,1-4H3,(H,30,34)(H,31,32);2*4-7,10-11,14-15,20-21H,8-9,12-13,16H2,1-3H3,(H,29,33)(H,30,31);2*5-11,13,16,18,21,23H,12,14-15,17H2,1-4H3,(H,26,30)(H,27,28);2*3-4,7-9,11,14-15,17,20,22H,5-6,10,12-13,16H2,1-2H3,(H,26,30)(H,27,28)/t21-,22+;20-,21+;20-,21-;21-,23+;21-,23-;20-,22+;20-,22-/m0001010/s1.
What are the key properties of (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide?
(3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide has a molecular weight of 3004.93 g/mol, XLogP of 28.56, 70 rotatable bonds, 14 hydrogen bond donors, and 26 hydrogen bond acceptors.
Where does this data come from?
All data for (3S)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-4-cyclopropyl-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylbutanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-(6-methyl-3-pyridinyl)propanamide;(3R)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-3-[1-(1,1-difluoroethyl)cyclopropyl]-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-3-pyridin-3-ylpropanamide;(3S)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide;(3R)-N-[(2S)-2-(dimethylamino)-3-(1H-indazol-5-yl)propyl]-5-methyl-3-phenylhexanamide is sourced from PubChem (CID 167582397), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).